At a glance
ClinicalIndex Comparison RecordN/ACompleted· 472 enrolled
Drug / intervention
Accolade stem +2 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
THE ATX REGISTRY ATX Register Accolade Stem & Trident/Tritanium Cup With X3 Insert International Multicentre Surveillance Register
In Brief
A clinical study evaluating Accolade stem, Accolade II stem, and 1 other intervention for Arthroplasty, Replacement, Hip. Completed, enrolled 472 participants across 8 sites in 4 countries.
Detailed Summary
The aim of this register is to determine the Accolade/Accolade II stem and Trident/Tritanium cup survivorship over years.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsArthroplasty, Replacement, Hip
CountriesBelgium, Netherlands, Sweden, United Kingdom
Collaborators--
Timeline
N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
Enrollment StartJan 2012
First PostedAug 2015
Primary CompletionNov 2024
TodayJul 2026
First PostedAug 13, 2015
Enrollment StartJan 1, 2012
Primary CompletionNov 12, 2024
TodayJul 2, 2026
Enrollment to primary: 12.9 yearsPosted 10.9 years ago
Interventions
Accolade stemdevice
Total hip replacement
Accolade II stemdevice
Total hip replacement
Trident/Tritanium cupdevice
Total hip replacement